Montauk Renewables, Inc. (MNTK) Guidance & Earnings Results

On 2026-08-05 Montauk Renewables, Inc. reaffirmed guidance: "RNG revenue $175-190M; RNG production 5.8-6.0M MMBtu; REG revenue…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

MNTKMontauk Renewables, Inc.Follow MNTK — free

Specialty Chemicals · Basic Materials

—

Price chart with a free account

Market cap: 303.2M
P/E TTM: 35.5
Dividend yield: —
52-week: —
Next earnings: 11 Nov, in 18 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
5 Aug 26	Reaffirmed	RNG revenue $175-190M; RNG production 5.8-6.0M MMBtu; REG revenue $23-26M · full year
6 May 26	Reaffirmed	RNG revenues $175-$190M, RNG production 5.8-6.0M MMBtu; REG revenues $33-$37M, production 195-207k MWh · full year
11 Mar 26	Reaffirmed	RNG revenue $175-190M, RNG production 5.8-6.1M MMBtu, Renewable Electricity revenue $35-41M, production 195-207K MWh · full year
5 Nov 25	Reaffirmed	RNG revenues $150-$170M, RNG production 5.8-6.0M MMBtu, REG revenues $17-$18M, REG production 175-180K MWh · full year
6 Aug 25	Reaffirmed	RNG revenues $150-170M; RNG production 5.8-6.0M MMBtu; REG revenues $17-18M; REG production 178-186k MWh · full year

Montauk Renewables, Inc. — questions

What guidance did Montauk Renewables, Inc. give?: On 2026-08-05: "RNG revenue $175-190M; RNG production 5.8-6.0M MMBtu; REG revenue $23-26M"
When does Montauk Renewables, Inc. report earnings?: Montauk Renewables, Inc.'s next earnings report is expected on 2026-11-11.

Every figure on this page comes from Montauk Renewables, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.